XML 76 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements for Operating Entities and Consolidated Funds
9 Months Ended
Sep. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurements for Operating Entities and Consolidated Funds
Fair Value Measurements for Operating Entities and Consolidated Funds
The following table presents the assets and liabilities that are measured at fair value on a recurring basis on the accompanying condensed consolidated statements of financial condition by caption and by level within the valuation hierarchy as of September 30, 2014 and December 31, 2013:
Operating Entities
 
Assets at Fair Value as of September 30, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
(dollars in thousands)
 
 
Securities owned and derivatives
 
 
 
 
 
 
 
US Government securities
$
1,009

 
$
—

 
$
—

 
$
1,009

Preferred stock
—

 
—

 
574

 
574

Common stocks
428,145

 
2,506

 
290

 
430,941

Restricted Common stocks
—

 
11,993

 
—

 
11,993

Convertible bonds
—

 
5,751

 
1,750

 
7,501

Corporate bonds
—

 
188,832

 
—

 
188,832

Warrants and rights
762

 
—

 
2,608

 
3,370

Mutual funds
16,382

 
—

 
—

 
16,382

Receivable on derivative contracts, at fair value
 
 
 
 
 
 
 
Futures
177

 
—

 
—

 
177

Currency forwards
—

 
291

 
—

 
291

Equity swaps
—

 
1,541

 
—

 
1,541

Options
5,172

 
—

 
28,785

 
33,957

Other investments


 


 


 
 
Portfolio Funds
—

 
36,530

 
60,474

 
97,004

Real estate investments
—

 
—

 
2,285

 
2,285

Lehman claim
—

 
—

 
360

 
360

 
$
451,647

 
$
247,444

 
$
97,126

 
$
796,217

 
Liabilities at Fair Value as of September 30, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(dollars in thousands)
Securities sold, not yet purchased and derivatives
 
 
 
 
 
 
 
Common stocks
$
208,990

 
$
41

 
$
—

 
$
209,031

Corporate bonds
—

 
58

 
—

 
58

Payable for derivative contracts, at fair value
 
 
 
 
 
 
 
Futures
24

 
—

 
—

 
24

Equity and credit default swaps
—

 
51

 
—

 
51

Options
2,509

 
—

 
28,785

 
31,294

Accounts payable, accrued expenses and other liabilities


 


 


 


          Contingent consideration liability (a)
$
—

 
$
—

 
$
6,419

 
$
6,419

 
$
211,523

 
$
150

 
$
35,204

 
$
246,877

(a) In accordance with the terms of purchase agreements for acquisitions that closed during 2012, the Company is required to pay to the sellers a portion of future net income of the acquired businesses, if certain revenue targets are achieved through the period ended October 2016. The Company estimated the contingent consideration liability using the income approach (discounted cash flow method) which requires the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts as of September 30, 2014 can range from $1.5 million to $10.9 million.
 
Assets at Fair Value as of December 31, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
(dollars in thousands)
 
 
Securities owned and derivatives
 
 
 
 
 
 
 
US Government securities
$
9

 
$
—

 
$
—

 
$
9

Preferred stock
—

 
—

 
324

 
324

Common stocks
171,277

 
2,103

 
3,559

 
176,939

Convertible bonds
—

 
4,008

 
1,950

 
5,958

Corporate bonds
—

 
121,372

 
—

 
121,372

Warrants and rights
107

 
—

 
5,805

 
5,912

Mutual funds
525

 
—

 
—

 
525

Receivable on derivative contracts, at fair value
 
 
 
 
 
 
 
Futures
285

 
—

 
—

 
285

Currency forwards
—

 
22

 
—

 
22

Equity swaps
—

 
70

 
—

 
70

Options
9,698

 
—

 
—

 
9,698

Other investments
 
 
 
 
 
 

Portfolio Funds
—

 
19,402

 
51,649

 
71,051

Real estate investments
—

 
—

 
2,088

 
2,088

Lehman claim
—

 
—

 
378

 
378

 
$
181,901

 
$
146,977

 
$
65,753

 
$
394,631

 
Liabilities at Fair Value as of December 31, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(dollars in thousands)
Securities sold, not yet purchased and derivatives
 
 
 
 
 
 
 
Common stocks
$
130,899

 
$
—

 
$
—

 
$
130,899

Corporate bonds
—

 
55

 
—

 
55

Payable for derivative contracts, at fair value
 
 
 
 
 
 
 
Futures
275

 
—

 
—

 
275

Currency forwards
—

 
301

 
—

 
301

Equity swaps
—

 
525

 
—

 
525

Options
6,573

 
—

 
—

 
6,573

Accounts payable, accrued expenses and other liabilities
 
 
 
 
 
 
 
          Contingent consideration liability (a)
—

 
—

 
6,937

 
6,937

 
$
137,747

 
$
881

 
$
6,937

 
$
145,565

(a) In accordance with the terms of purchase agreements for acquisitions that closed during 2012, the Company is required to pay to the sellers a portion of future net income of the acquired businesses, if certain revenue targets are achieved through the period ended October 2016. The Company estimated the contingent consideration liability using the income approach (discounted cash flow method) which requires the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts can range from $2.1 million to $13.8 million.
Consolidated Funds' investments
 
Assets at Fair Value as of September 30, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
(dollars in thousands)
 
 
Other investments
 
 
 
 
 
 
 
Portfolio Funds
$
—

 
$
49,653

 
$
146,987

 
$
196,640

Lehman claims
—

 
—

 
361

 
361

 
$
—

 
$
49,653

 
$
147,348

 
$
197,001

 
Assets at Fair Value as of December 31, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
 
(dollars in thousands)
 
 
Other investments
 
 
 
 
 
 
 
Portfolio Funds
—

 
26,964

 
155,674

 
182,638

Lehman claims
—

 
—

 
4,842

 
4,842

 
$
—

 
$
26,964

 
$
160,516

 
$
187,480

The following table includes a rollforward of the amounts for the three and nine months ended September 30, 2014 and 2013, for financial instruments classified within level 3. The classification of a financial instrument within level 3 is based upon the significance of the unobservable inputs to the overall fair value measurement.

 
Three Months Ended September 30, 2014
 
Balance at June 30, 2014
 
Transfers in
 
Transfers out
 
Purchases/(covers)
 
(Sales)/shorts
 
Realized and Unrealized gains/losses
 
Balance at September 30, 2014
 
Change in unrealized gains/(losses) relating to instruments still held (1)
 
(dollars in thousands)
Operating Entities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
$
2,574

 
$
—

 
$
(2,000
)
(b)
$
—

 
$
—

 
$
—

 
$
574

 
$
—

Common stocks
419

 
—

 
—

 
—

 
(1
)
 
(128
)
 
290

 
(14
)
Convertible bonds
1,750

 
—

 
—

 
—

 
—

 
—

 
1,750

 
—

Options, asset
37,658

 
—

 
—

 
—

 
—

 
(8,873
)
 
28,785

 
(8,873
)
Options, liability
37,658

 
—

 
—

 
—

 
—

 
(8,873
)
 
28,785

 
(8,873
)
Warrants and rights
3,346

 
—

 
—

 
57

 
(57
)
 
(738
)
 
2,608

 
(434
)
Portfolio Funds
62,437

 
—

 
—

 
3,049

 
(5,320
)
 
308

 
60,474

 
373

Real estate
2,262

 
—

 
—

 
—

 
—

 
23

 
2,285

 
23

Lehman claim
418

 
—

 
—

 
—

 
—

 
(58
)
 
360

 
(58
)
Contingent consideration liability
6,783

 
—

 
—

 
—

 
(364
)
 
—

 
6,419

 
—

Consolidated Funds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portfolio Funds
145,371

 
—

 
—

 
—

 
(409
)
 
2,025

 
146,987

 
1,962

Lehman claim
4,090

 
—

 
—

 
—

 
(3,731
)
 
2

 
361

 
2


 
Three Months Ended September 30, 2013
 
Balance at June 30, 2013
 
Transfers in
 
Transfers out
 
Purchases/(covers)
 
(Sales)/shorts
 
Realized and Unrealized gains/losses
 
Balance at September 30, 2013
 
Change in unrealized gains/(losses) relating to instruments still held (1)
 
(dollars in thousands)
Operating Entities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
$
333

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
333

 
$
—

Common stocks
2,273

 
—

 
—

 
—

 
(2
)
 
(162
)
 
2,109

 
(161
)
Warrants and rights
2,136

 
—

 
—

 
—

 
—

 
531

 
2,667

 
(76
)
Portfolio Funds
43,343

 


 
—

 
6,491

 
(289
)
 
2,158

 
51,703

 
1,446

Real estate
2,158

 
—

 
—

 
—

 
—

 
(31
)
 
2,127

 
(31
)
Lehman claim
278

 
—

 
—

 
—

 
—

 
280

 
558

 
280

Contingent consideration liability
7,928

 
—

 
—

 
—

 
(94
)
 
—

 
7,834

 
—

Consolidated Funds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portfolio Funds
177,848

 
—

 
—

 
—

 
(17,886
)
 
1,124

 
161,086

 
635

Lehman claim
15,434

 
—

 
—

 
—

 
—

 
1,049

 
16,483

 
1,049



 
Nine Months Ended September 30, 2014
 
Balance at December 31, 2013
 
Transfers in
Transfers out
 
Purchases/(covers)
 
(Sales)/shorts
 
Realized and Unrealized gains/losses
 
Balance at September 30, 2014
 
Change in unrealized gains/losses relating to instruments still held (1)
 
(dollars in thousands)
 
 
Operating Entities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
$
324

 
$
—

$
(2,000
)
(b)
$
2,250

 
$
—

 
$
—

 
$
574

 
$
—

Common stocks
3,559

 
—

(3,150
)
(b)
9

 
(1
)
 
(127
)
 
290

 
(13
)
Convertible bonds
1,950

 
—

—

 
—

 
(200
)
 
—

 
1,750

 
—

Options, asset
—

 
—

—

 
35,710

 
—

 
(6,925
)
 
28,785

 
(6,925
)
Options, liability
—

 
—

—

 
35,710

 
—

 
(6,925
)
 
28,785

 
(6,925
)
Warrants and Rights
5,805

 
—

—

 
57

 
(1,385
)
 
(1,869
)
 
2,608

 
(432
)
Portfolio Funds
51,649

 
—

—

 
12,234

 
(8,340
)
 
4,931

 
60,474

 
3,585

Real estate
2,088

 
—

—

 
50,000

 
(50,027
)
 
224

 
2,285

 
224

Lehman claim
378

 
—

—

 
—

 
(76
)
 
58

 
360

 
58

Contingent consideration liability
6,937

 
—

—

 
—

 
(518
)
 
—

 
6,419

 
—

Consolidated Funds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portfolio Funds
155,674

 
—

—

 
—

 
(16,439
)
 
7,752

 
146,987

 
7,689

Lehman claim
4,842

 
—

—

 
—

 
(4,711
)
 
230

 
361

 
230

 
Nine Months Ended September 30, 2013
 
Balance at December 31, 2012
 
Transfers in
 
 
Transfers out
 
 
Purchases/(covers)
 
(Sales)/shorts
 
Realized and Unrealized gains/losses
 
Balance at September 30, 2013
 
Change in unrealized gains/losses relating to instruments still held (1)
 
(dollars in thousands)
Operating Entities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred stock
$
2,332

 
$
—

 
 
$
(2,000
)
(b)
 
$
—

 
$
—

 
$
1

 
$
333

 
$
1

Common stocks
2,549

 
—

 
 
—

 
 
—

 
(275
)
 
(165
)
 
2,109

 
(424
)
Corporate Bond
515

 
—

 
 
—


 
2,735

 
(3,346
)
 
96

 
—

 
—

Warrants and Rights, asset
1,713

 
290

(a)
 
—


 
166

 
(110
)
 
608

 
2,667

 
760

Warrants and Rights, liability
3

 
—

 
 
—

 
 
—

 
—

 
(3
)
 
—

 
—

Portfolio Funds
25,670

 
13,128

 
 
—

 
 
16,560

 
(7,821
)
 
4,166

 
51,703

 
4,542

Real estate
1,864

 
—

 
 
—

 
 
—

 
—

 
263

 
2,127

 
263

Lehman claim
706

 
—

 
 
—

 
 
—

 
(382
)
 
234

 
558

 
234

Contingent consideration liability
8,116

 
—

 
 
—

 
 
—

 
(282
)
 
—

 
7,834

 
—

Consolidated Funds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portfolio Funds
182,920

 
—


 
—


 
—

 
(27,835
)
 
6,001

 
161,086

 
5,092

Lehman claim
14,124

 
—

 
 
—

 
 
—

 
(1,449
)
 
3,808

 
16,483

 
2,448


(1) Unrealized gains/losses are reported in other income (loss) in the accompanying condensed consolidated statements of
operations.
(a) The security was acquired through an acquisition (See Note 2).
(b) The company completed an initial public offering.
All realized and unrealized gains (losses) in the table above are reflected in other income (loss) in the accompanying condensed consolidated statements of operations.
Certain assets and liabilities are measured at fair value on a nonrecurring basis and therefore are not included in the tables above.
The Company recognizes all transfers and the related unrealized gain (loss) at the beginning of the reporting period.
Transfers between level 1 and 2 generally relate to whether the principal market for the security becomes active or inactive. Transfers between level 2 and 3 generally relate to whether significant relevant observable inputs are available for the fair value measurements or due to change in liquidity restrictions for the investments.
During the three and nine months ended September 30, 2014 and 2013, there were no transfers between level 1 and level 2 assets and liabilities.
The following table includes quantitative information as of September 30, 2014 for financial instruments classified within level 3. The table below quantifies information about the significant unobservable inputs used in the fair value measurement of the Company's level 3 financial instruments.
 
Quantitative Information about Level 3 Fair Value Measurements
 
Fair Value at September 30, 2014
 
Valuation techniques
 
Unobservable Inputs
 
Range
 
 
 
 
 
 
 
 
Level 3 Assets
 
 
 
 
 
 
 
Common and preferred stocks
$
324

 
Market multiples and option pricing method

Volatility Market multiples

45% 2x to 3x
Warrants and rights, net
2,608

 
Model based
 
Volatility
 
20% to 60% (weighted average 39%)
Options
28,785

 
Option pricing models, credit valuation adjustment, debt valuation adjustment
 
Volatility Credit spreads
 
30% to 45% 600bps - 750 bps
Other level 3 assets (a)
212,757

 
 
 
 
 
 
Total level 3 assets
244,474

 
 
 
 
 
 
Level 3 Liabilities
 
 
 
 
 
 
 
Options
28,785

 
Option pricing models, credit valuation adjustment, debt valuation adjustment
 
Volatility Credit spreads
 
30% to 45% 600bps - 750 bps
Contingent consideration
6,419

 
Discounted cash flows
 
Projected cash flow and discount rate
 
6% to 9%
Total level 3 liabilities
$
35,204

 
 
 
 
 
 
(a)
Quantitative disclosures of unobservable inputs and assumptions are not required for investments for which NAV per share is used as a practical expedient to determine fair value, as their redemption features rather than observability of inputs cause them to be classified as a level 3 type asset within the fair value hierarchy. In addition, the fair value of the Consolidated Funds' investments are determined based on net asset value and therefore quantitative disclosures are not included in the table above. The quantitative disclosures also exclude financial instruments for which the determination of fair value is based on prices from prior transactions.
During the three months ended June 30, 2014, the Company wrote down the value of its investment in CBOE SE as a result of an impairment which was considered other than temporary. The level of impairment is based on the fair value of the investment as measured on a non-recurring basis as of June 30, 2014 (See Note 5). The Company classified its investment in CBOE as level 3 on this date. The fair value reflects the weighted average of both the indicative bid level and the liquidation value.
The Company has established valuation policies and procedures and an internal control infrastructure over its fair value measurement of financial instruments which includes ongoing oversight by the valuation committee as well as periodic audits performed by the Company's internal audit group. The valuation committee is comprised of senior management, including non-investment professionals, who are responsible for overseeing and monitoring the pricing of the Company's investments, including the review of the results of the independent price verification process, approval of new trading asset classes and use of applicable pricing models and approaches.
The US GAAP fair value leveling hierarchy is designated and monitored on an ongoing basis. In determining the designation, the Company takes into consideration a number of factors including the observability of inputs, liquidity of the investment and the significance of a particular input to the fair value measurement. Designations, models, pricing vendors, third party valuation providers and inputs used to derive fair market value are subject to review by the valuation committee and the internal audit group. The Company reviews its valuation policy guidelines on an ongoing basis and may adjust them in light of, improved valuation metrics and models, the availability of reliable inputs and information, and prevailing market conditions. The Company reviews a daily profit and loss report, as well as other periodic reports, and analyzes material changes from period-to-period in the valuation of its investments as part of its control procedures. The Company also performs back testing on a regular basis by comparing prices observed in executed transactions to previous valuations.
The fair market value for level 3 securities may be highly sensitive to the use of industry standard models, unobservable inputs and subjective assumptions. The degree of fair market value sensitivity is also contingent upon the subjective weight given to specific inputs and valuation metrics. The Company holds various equity and debt instruments where different weight may be applied to industry standard models representing standard valuation metrics such as: discounted cash flows, market multiples, comparative transactions, capital rates, recovery rates and timing, and bid levels. Generally, changes in the weights ascribed to the various valuation metrics and the significant unobservable inputs in isolation may result in significantly lower or higher fair value measurements. Volatility levels for warrants and options are not readily observable and subject to interpretation. Changes in capital rates, discount rates and replacement costs could significantly increase or decrease the valuation of the real estate investments. The interrelationship between unobservable inputs may vary significantly amongst level 3 securities as they are generally highly idiosyncratic. Significant increases (decreases) in any of those inputs in isolation can result in a significantly lower (higher) fair value measurement.